Skip to main content

Closed

XENE: Xenon Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-30.4%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio27.79×

Xenon Pharmaceuticals Inc.

XENENASDAQ Global Market·USD·Closed

Xenon Pharmaceuticals Inc.

XENENASDAQ·USD·Closed

$62.67

−2.37%

$62.67

−$1.52 (2.37%)

52W Range

77thpctl

Volume

0.51×avg

Mkt Cap

6.06BUSD

P/E

-13.3TTM

Div Yield

–ann

52W Range

77thpctl

Volume

0.51×avg

Market Cap

6.06BUSD

P/E Ratio

-13.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings